CLAIM #2948 · Abbott Laboratories (ABT) · 2022Q3 earnings call · Oct 18, 2022 · due Dec 31, 2028
“We believe this is a $10 billion franchise by 2028.”
Robert Ford · CEO
PENDING
graded after results covering Dec 31, 2028 are reported
How to check this claim
Look at: Annual revenue of the franchise/product line referenced
It came true if: Annual revenue >= $10 billion
Where: Company-disclosed segment or franchise revenue (10-K, investor presentation, or earnings call commentary)
Verify independently
SEC filings for ABT ↗ · Claim quote is verbatim from the 2022Q3 earnings call.